When Randomization Is Not Enough: Divergent Beta-Blocker Trials and the Illusion of Universal Causality
{{output}}
Two contemporary randomized trials of β-blocker therapy after myocardial infarction (MI) reached apparently conflicting conclusions. REBOOT, conducted in Spain and Italy, found no reduction in death or major cardiovascular events among patients with preserved... ...
